Literature DB >> 10937917

Executive control functions in degenerative dementias: a comparative review.

L M Duke1, A W Kaszniak.   

Abstract

This paper reviews the literature concerning executive control impairments in degenerative dementias. The construct of executive control functioning is examined, as is the neuroanatomy of frontal-subcortical networks, believed to underlie executive function (EF) impairments. The pattern of EF impairments in Alzheimer's disease (AD) which affects temporal and parietal brain regions most severely is contrasted with observed executive dysfunctions in patients with dementias involving degeneration of primarily frontal and frontal-subcortical brain areas. EF impairments are present in each of these types of dementing illnesses. Although EF impairments are present in AD, they are less prominent than the memory disorder in the neuropsychological profile of the disease and tend to become more pronounced later in the course of the illness. In contrast, patients with frontal or frontal-subcortical dementia may demonstrate executive dysfunction, which occurs earlier in the disease progression and may be initially more severe.

Entities:  

Mesh:

Year:  2000        PMID: 10937917     DOI: 10.1023/a:1009096603879

Source DB:  PubMed          Journal:  Neuropsychol Rev        ISSN: 1040-7308            Impact factor:   7.444


  94 in total

1.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

2.  A behavioral analysis of degree of reinforcement and ease of shifting to new responses in a Weigl-type card-sorting problem.

Authors:  D A GRANT; E A BERG
Journal:  J Exp Psychol       Date:  1948-08

3.  The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

Authors:  G Blessed; B E Tomlinson; M Roth
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

Review 4.  Assessment of depression and dementia during the late years.

Authors:  L W Thompson; V Gong; E Haskins; D Gallagher
Journal:  Annu Rev Gerontol Geriatr       Date:  1987

5.  Executive dysfunction in early Alzheimer's disease.

Authors:  G Binetti; E Magni; A Padovani; S F Cappa; A Bianchetti; M Trabucchi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-01       Impact factor: 10.154

6.  Internal versus external cues and the control of attention in Parkinson's disease.

Authors:  R G Brown; C D Marsden
Journal:  Brain       Date:  1988-04       Impact factor: 13.501

7.  Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology.

Authors:  A Brun
Journal:  Arch Gerontol Geriatr       Date:  1987-09       Impact factor: 3.250

8.  [Frontal syndrome of progressive supranuclear palsy].

Authors:  J Cambier; M Masson; F Viader; J Limodin; A Strube
Journal:  Rev Neurol (Paris)       Date:  1985       Impact factor: 2.607

Review 9.  Psychological dysfunction accompanying subcortical dementias.

Authors:  J L Cummings; D F Benson
Journal:  Annu Rev Med       Date:  1988       Impact factor: 13.739

10.  Development of neuropsychological deficits in Huntington's disease.

Authors:  R C Josiassen; L M Curry; E L Mancall
Journal:  Arch Neurol       Date:  1983-12
View more
  24 in total

Review 1.  Metamemory experiments in neurological populations: a review.

Authors:  Jasmeet K Pannu; Alfred W Kaszniak
Journal:  Neuropsychol Rev       Date:  2005-09       Impact factor: 7.444

Review 2.  Executive function and the frontal lobes: a meta-analytic review.

Authors:  Julie A Alvarez; Eugene Emory
Journal:  Neuropsychol Rev       Date:  2006-03       Impact factor: 7.444

3.  Validation of a self-administered computerized system to detect cognitive impairment in older adults.

Authors:  Samuel D Brinkman; Robert J Reese; Larry A Norsworthy; Donna K Dellaria; Jacob W Kinkade; Jared Benge; Kimberly Brown; Anna Ratka; James W Simpkins
Journal:  J Appl Gerontol       Date:  2012-09-18

4.  Non-alcoholic fatty liver disease, liver fibrosis score and cognitive function in middle-aged adults: The Framingham Study.

Authors:  Galit Weinstein; Kendra Davis-Plourde; Jayandra J Himali; Shira Zelber-Sagi; Alexa S Beiser; Sudha Seshadri
Journal:  Liver Int       Date:  2019-06-26       Impact factor: 5.828

Review 5.  Neuropsychological assessment of patients with dementing illness.

Authors:  Julie A Fields; Tanis J Ferman; Bradley F Boeve; Glenn E Smith
Journal:  Nat Rev Neurol       Date:  2011-11-01       Impact factor: 42.937

6.  Executive functions and the down-regulation and up-regulation of emotion.

Authors:  Anett Gyurak; Madeleine S Goodkind; Joel H Kramer; Bruce L Miller; Robert W Levenson
Journal:  Cogn Emot       Date:  2011-05-24

Review 7.  The cart before the horse: When cognitive neuroscience precedes cognitive neuropsychology.

Authors:  Daniel Agis; Argye E Hillis
Journal:  Cogn Neuropsychol       Date:  2017-05-31       Impact factor: 2.468

8.  Judgment in older adults: development and psychometric evaluation of the Test of Practical Judgment (TOP-J).

Authors:  L A Rabin; M J Borgos; A J Saykin; H A Wishart; P K Crane; K E Nutter-Upham; L A Flashman
Journal:  J Clin Exp Neuropsychol       Date:  2007-10       Impact factor: 2.475

9.  Do tests of executive functioning predict ability to downregulate emotions spontaneously and when instructed to suppress?

Authors:  Anett Gyurak; Madeleine S Goodkind; Anita Madan; Joel H Kramer; Bruce L Miller; Robert W Levenson
Journal:  Cogn Affect Behav Neurosci       Date:  2009-06       Impact factor: 3.282

10.  Judgment in Older Adults with Normal Cognition, Cognitive Complaints, MCI, and Mild AD: Relation to Regional Frontal Gray Matter.

Authors:  Laura A Rabin; Andrew J Saykin; John D West; Marlana J Borgos; Heather A Wishart; Katherine E Nutter-Upham; Laura A Flashman; Robert B Santulli
Journal:  Brain Imaging Behav       Date:  2009-06       Impact factor: 3.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.